Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

Philip Q. Bao; Ramesh K. Ramanathan; Alyssa Krasinkas; Nathan Bahary; Barry C. Lembersky; David L. Bartlett; Steven J. Hughes; Kenneth K. Lee; A. James Moser; Herbert J. Zeh

doi:10.1245/s10434-011-1681-8

Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S323
Journal	Annals of Surgical Oncology
Volume	18
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1245/s10434-011-1681-8
State	Published - Dec 2011
Externally published	Yes

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-011-1681-8

Cite this

Bao, P. Q., Ramanathan, R. K., Krasinkas, A., Bahary, N., Lembersky, B. C., Bartlett, D. L., Hughes, S. J., Lee, K. K., James Moser, A., & Zeh, H. J. (2011). Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9). Annals of Surgical Oncology, 18(SUPPL. 3), S323. https://doi.org/10.1245/s10434-011-1681-8

Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9). / Bao, Philip Q.; Ramanathan, Ramesh K.; Krasinkas, Alyssa et al.
In: Annals of Surgical Oncology, Vol. 18, No. SUPPL. 3, 12.2011, p. S323.

Research output: Contribution to journal › Comment/debate › peer-review

Bao, PQ, Ramanathan, RK, Krasinkas, A, Bahary, N, Lembersky, BC, Bartlett, DL, Hughes, SJ, Lee, KK, James Moser, A & Zeh, HJ 2011, 'Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)', Annals of Surgical Oncology, vol. 18, no. SUPPL. 3, pp. S323. https://doi.org/10.1245/s10434-011-1681-8

@article{63148313e53a49898bb3446e49b9c055,

title = "Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)",

author = "Bao, {Philip Q.} and Ramanathan, {Ramesh K.} and Alyssa Krasinkas and Nathan Bahary and Lembersky, {Barry C.} and Bartlett, {David L.} and Hughes, {Steven J.} and Lee, {Kenneth K.} and {James Moser}, A. and Zeh, {Herbert J.}",

year = "2011",

month = dec,

doi = "10.1245/s10434-011-1681-8",

language = "English (US)",

volume = "18",

pages = "S323",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "SUPPL. 3",

}

TY - JOUR

T1 - Erratum

T2 - Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

AU - Bao, Philip Q.

AU - Ramanathan, Ramesh K.

AU - Krasinkas, Alyssa

AU - Bahary, Nathan

AU - Lembersky, Barry C.

AU - Bartlett, David L.

AU - Hughes, Steven J.

AU - Lee, Kenneth K.

AU - James Moser, A.

AU - Zeh, Herbert J.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=82955182169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955182169&partnerID=8YFLogxK

U2 - 10.1245/s10434-011-1681-8

DO - 10.1245/s10434-011-1681-8

M3 - Comment/debate

AN - SCOPUS:82955182169

SN - 1068-9265

VL - 18

SP - S323

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - SUPPL. 3

ER -

Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this